Reviewed by Michael Gill, B. Sc.
25 Age Related Macular Degeneration Clinical Trials Near Me
Top Hospitals for Age Related Macular Degeneration Clinical Trials
Image of Sierra Eye Associates in Nevada.
Sierra Eye Associates
Reno
13Active Trials
39All Time Trials for Age Related Macular Degeneration
2013First Age Related Macular Degeneration Trial
Image of Retina Consultants of Orange County in California.
Retina Consultants of Orange County
Fullerton
10Active Trials
19All Time Trials for Age Related Macular Degeneration
2014First Age Related Macular Degeneration Trial
Top Cities for Age Related Macular Degeneration Clinical Trials
Age Related Macular Degeneration Clinical Trials by Phase of Trial
Phase < 1 Age Related Macular Degeneration Clinical Trials
4Active Age Related Macular Degeneration Clinical Trials
4Number of Unique Treatments
3Number of Active Locations
MB-102 and Zeiss FF450 fundus cameraVitamin A PalmitateVitamin A palmitatetreatment
Age Related Macular Degeneration Clinical Trials by Age Group
18+ Age Related Macular Degeneration Clinical Trials
84Active Age Related Macular Degeneration Clinical Trials
Avacincaptad pegol 2 mg intravitreal injection'Scotoma awareness' TrainingTraining visual sensitivityPistachio GroupRO7250284ZimuraDriving Decision AidMB-102 and Zeiss FF450 fundus camera
Most Recent Age Related Macular Degeneration Clinical Trials
Top Treatments for Age Related Macular Degeneration Clinical Trials
Treatment Name
Active Age Related Macular Degeneration Clinical Trials
All Time Trials for Age Related Macular Degeneration
First Recorded Age Related Macular Degeneration Trial
Zimura
2
5
2016
ALK-001
2
2
2015
RGX-314
2
4
2017
RGX-314 Dose 2
2
2
2020
Aflibercept
2
43
2012
Recently Completed Studies with FDA Approved Treatments for Age Related Macular Degeneration
Treatment
Year
Sponsor
RBM-007 Injectable Solution
2021
Maturi, Raj K., M.D., P.C.
AXT107 0.1 mg
2021
AsclepiX Therapeutics, Inc.
EYP-1901
2021
EyePoint Pharmaceuticals, Inc.
MHU650
2020
Novartis Pharmaceuticals
RBM-007
2020
Ribomic USA Inc
UBX1325
2020
Unity Biotechnology, Inc.
SB15 (Proposed aflibercept biosimilar)
2020
Samsung Bioepis Co., Ltd.
AR-13503 63.6 Dose
2019
Aerie Pharmaceuticals
Subcutaneous elamipretide through the elamipretide delivery system
2019
Stealth BioTherapeutics Inc.
Faricimab
2019
Hoffmann-La Roche

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 20th, 2021

Last Reviewed: October 26th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.